Skip to main content

JD

Analyst

Equibles does not estimate personal net worth.

About JD

JD has spoken on 1 investor event across 1 company, most recently for Nektar Therapeutics on June 3, 2026. The companies whose calls JD spoke on are classified in the Healthcare sector.

JD on recent calls

“I think it's one of the components and approaches medically that we've really taken and, you know, and really defines, you know, our pipeline, and it defines our work, and I think we've established a level of expertise and certainly the most clinically mature data. in this field, demonstrating that ResPeg, with its…”
Company Representative, 2026 Jefferies Global Healthcare Conference ·

Company network

Recent activity